Martha Aregbesola
Nurse Practitioner · Franklin, WINPI 1013096262
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $28,638 of the $31,717 with a category attached, or 90.3%. AbbVie accounts for 96.8% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2021 at $13,497 and has fallen 69.4% since, to $4,135 in 2025. Among nurse practitioner clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 181 payments — averaging $175.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$31K
- Teva Pharmaceuticals USA, Inc.$559
- Lundbeck LLC$298
- Ipsen Biopharmaceuticals, Inc$54
- Supernus Pharmaceuticals, Inc.$40
- TG Therapeutics, Inc.$38
- plus $27 from 1 others
What the payments were for
- Speaking & faculty fees$28,63890%
- Travel & lodging$3921%
- Food & beverage$2,6878%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 128 | $30,702 |
| Teva Pharmaceuticals USA, Inc. | 34 | $559 |
| Lundbeck LLC | 11 | $298 |
| Ipsen Biopharmaceuticals, Inc | 2 | $54 |
| Supernus Pharmaceuticals, Inc. | 3 | $40 |
| TG Therapeutics, Inc. | 2 | $38 |
| Genentech USA, Inc. | 1 | $27 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$31,717 in reported general payments places this provider in the 95th percentile of 3,478 nurse practitioner providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| UbrelvyUbrogepant | 118 | $147,670 |
| Nurtec OdtRimegepant Sulfate | 104 | $117,702 |
| Aimovig AutoinjectorErenumab-Aooe | 94 | $84,524 |
| QuliptaAtogepant | 52 | $60,484 |
| Trokendi XrTopiramate | 30 | $48,377 |
| Emgality PenGalcanezumab-Gnlm | 56 | $47,054 |
| Ajovy AutoinjectorFremanezumab-Vfrm | 17 | $25,150 |
| Sumatriptan Succinate | 113 | $9,440 |
| Eletriptan HbrEletriptan Hydrobromide | 26 | $3,898 |
| Zolmitriptan | 17 | $3,229 |
| Baclofen | 165 | $2,193 |
| Gabapentin | 96 | $2,126 |
| Pregabalin | 19 | $1,107 |
| Propranolol Hcl ErPropranolol Hcl | 33 | $989 |
| Butalbital-Acetaminophen-CaffeButalb/Acetaminophen/Caffeine | 97 | $988 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieUbrelvy, Qulipta | $30,702 | $208,154170 claims |
| Supernus Pharmaceuticals, Inc.Trokendi Xr | $40 | $48,37730 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,478 nurse practitioner providers in Wisconsin.
Other nurse practitioner in Franklin
- Laura BurgmeierFranklin$6K
- Jillian StancevicFranklin$5K
- Jodi StrongStevens Point$246K
- Jo Ellen FrawleyPrairie du Sac$194K
- Trisha WilcoxMilwaukee$174K
- Sally BowaGreen Bay$117K
- Christina SauldMilwaukee$111K
- Melissa WendellWausau$98K
- Nicole BarteltWaukesha$85K
- Kari FisherPrairie du Sac$57K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.